MYC-orchestrated RhoA transcription has been shown to be pivotal in cell invasion and cancer metastasis [18], and MYC-regulated genes are one of the major targets held responsible for the antiproliferative effects of BET inhibitors in DLBCL [11,12,19]. Here, MYC is linked to cancer.